Concord Drugs Limited (BOM:538965)
India · Delayed Price · Currency is INR 70.40
-2.49 (-3.42%)
At close: Aug 17, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 927.52 million as of August 17, 2026. Its market cap has increased by 78.23% in one year.
Market Cap
927.52M
Enterprise Value
1.07B
Revenue
860.69M
Ranking
n/a
PE Ratio
40.94
Stock Price
70.40
ChartMarket Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 927.52M, an increase of 540.54%. That is a compound annual growth rate of 17.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 927.52M | -14.65% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lactose (India) | 1.35B |
| Pharmaids Pharmaceuticals | 1.18B |
| Aayush Wellness | 1.16B |
| Denis Chem Lab | 978.86M |
| Makers Laboratories | 921.05M |
| Mercury Laboratories | 917.16M |
| Amwill Health Care | 855.15M |
| Onyx Biotec | 797.82M |